Exercises and Stretches for Hip Pain

Health & Lifestyle
446

Listen to article (english)

Translate to Spanish or other 102 languages!

Flexibility and strength exercises are key to relieving hip pain. Image for illustration purposes
Flexibility and strength exercises are key to relieving hip pain. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

Hip pain can have a range of causes, from minor injury to chronic inflammation. In many cases, gently exercising and stretching the hips can help relieve pain and restore mobility.

There are many possible causes of hip pain, ranging from muscle strains and injuries to arthritis and other inflammatory disorders.

- Advertisement -

Follow the link Below to Medical News Today ofr the full story:

https://www.medicalnewstoday.com/articles/325029?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-05-30&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS Highlights Importance of Women’s Health on Community
Next article
TSC Achieves 100% Passing Rate & Job Placement for 2025 DMS Class

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -